Baku 5° C
India’s Covaxin gets WHO approval for emergency use listing
Health
- 03 November, 2021
- 13:42
Bharat Biotech’s Covaxin has got WHO approval as the technical advisory team has recommended the India-made vaccine for emergency use listing for 18 years and above, Report informs referring to Hindustan Times.
This marks a major victory for India’s journey in vaccination against Covid-19.
Covaxin is a vaccine, completely “made in India,” by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research.
The emergency listing got delayed last month as the technical advisory group sought some additional clarification from Bharat Biotech for its final risk assessment.
The technical advisory group met on November 3 to take the final call, and Covaxin has been recommended for emergency use listing.
Author
Latest News
00:27
President: All Azerbaijanis should know and do know that a strong Azerbaijani state stands behind them
Domestic policy00:25
Azerbaijani President: We can be proud of this year's achievements in economic development
Domestic policy00:22
Azerbaijani President: We have not allowed and will not allow anyone to interfere in our affairs
Foreign policy00:19
President: Issue of restoring our territorial integrity and its global recognition has been resolved
Domestic policy00:17
President Ilham Aliyev: Today Azerbaijan is treated with great respect in the world
Domestic policy00:15
President Ilham Aliyev: The world now recognizes our Victory and acknowledges we are right
Foreign policy00:13
President Ilham Aliyev: Azerbaijan's Armed Forces significantly strengthened over past five years
Domestic policy00:08
President: Historic Victory in the Patriotic War will forever remain with us
Domestic policy00:06